Guevara-Gutiérrez Elizabeth, Tlacuilo-Parra Alberto, Gutiérrez-Fajardo Pedro, Sánchez-Tenorio Tania, Barba-Gómez Fernando, Miranda-Díaz Alejandra
Department of Dermatology, Dermatologic Institute of Jalisco, Secretary of Health Jalisco, Guadalajara, Jalisco, México.
Medical Research Division, UMAE Pediatric Hospital, CMNO, IMSS, Guadalajara, Jalisco, México.
Indian J Dermatol Venereol Leprol. 2017 Mar-Apr;83(2):190-194. doi: 10.4103/0378-6323.198445.
Hyperinsulinism is related to the presence of acanthosis nigricans and atherosclerosis; however, we were unable to find any study on the prevalence of atherosclerosis in acanthosis nigricans.
To evaluate the prevalence of carotid atherosclerosis and metabolic alterations in Mexican patients with acanthosis nigricans.
We carried out a cross-sectional study that included 45 patients with acanthosis nigricans, age- and gender-matched with 45 healthy participants. Volunteers with any comorbidity or taking weight reduction, glucose- and/or lipid-lowering medication or drugs capable of causing acanthosis nigricans were not included in the study. B-mode ultrasound tests were done to measure the carotid intima-media thickness. Body mass index, insulin, glucose and lipid blood serum levels were measured. Chi-square or Fisher's exact test and paired Student t-test were used for statistical analysis.
Carotid intima-media thickness was greater in patients with acanthosis nigricans (mean 0.52 mm vs. 0.46 mm, P = 0.002). The prevalence of abnormal intima-media thickness was higher in patients with acanthosis nigricans versus healthy participants (62.2% vs. 35.5%, P = 0.02). The same occurred with hyperinsulinemia (73.3% vs. 13.3%, P< 0.001), insulin resistance (86.6% vs. 33.3%, P< 0.001), obesity (86.6% vs. 13.3%, P< 0.001) and dyslipidemia (95.5% vs. 77.7%, P = 0.01).
The sample size is small and serum markers of cardiovascular risk were not measured.
Acanthosis nigricans is a skin marker for metabolic disturbances and is also associated with carotid atherosclerosis, a finding which is not well documented. We propose that individuals with acanthosis nigricans should be routinely evaluated for these cardiovascular risks.
高胰岛素血症与黑棘皮病和动脉粥样硬化的存在有关;然而,我们未能找到任何关于黑棘皮病患者动脉粥样硬化患病率的研究。
评估墨西哥黑棘皮病患者颈动脉粥样硬化的患病率和代谢改变。
我们进行了一项横断面研究,纳入了45例黑棘皮病患者,并与45名年龄和性别匹配的健康参与者进行对照。患有任何合并症或正在服用减肥、降糖和/或降脂药物或可能导致黑棘皮病的药物的志愿者未纳入本研究。采用B型超声检查测量颈动脉内膜中层厚度。测量体重指数、胰岛素、血糖和血脂血清水平。采用卡方检验或Fisher精确检验以及配对学生t检验进行统计分析。
黑棘皮病患者的颈动脉内膜中层厚度更大(平均0.52毫米对0.46毫米,P = 0.002)。黑棘皮病患者内膜中层厚度异常的患病率高于健康参与者(62.2%对35.5%,P = 0.02)。高胰岛素血症(73.3%对13.3%,P<0.001)、胰岛素抵抗(86.6%对33.3%,P<0.001)、肥胖(86.6%对13.3%,P<0.001)和血脂异常(95.5%对77.7%,P = 0.01)的情况也是如此。
样本量小,未测量心血管风险的血清标志物。
黑棘皮病是代谢紊乱的皮肤标志物,也与颈动脉粥样硬化有关,这一发现尚无充分记录。我们建议对黑棘皮病患者进行这些心血管风险的常规评估。